NCT04613375View on ClinicalTrials.gov

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

CompletedOBSERVATIONAL
Enrollment

1,821

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

October 25, 2023

Study Completion Date

March 24, 2024

Conditions
Community Acquired Pneumonia (CAP)
Interventions
DIAGNOSTIC_TEST

Urine sample collection

Serotype specific UAD (urinary antigen detection) test

DIAGNOSTIC_TEST

Saliva collection

Streptococcus pneumonia identification in saliva samples by culture or PCR / RSV identification in saliva samples by PCR

Trial Locations (5)

28905

Hospital Universitarios De Getafe, Getafe

28911

Hospital Universitario Severo Ochoa, Leganés

28922

Hospital Universitario Fundación Alcorcón, Alcorcón

28933

Hospital Universitario Rey Juan carlos, Móstoles

28935

Hospital Universitario de Mostoles, Móstoles

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04613375 - PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older | Biotech Hunter | Biotech Hunter